The FDA published a security critique of orlistat in 2010 on account of exceptional stories of significant liver injuries in persons utilizing it. The FDA found no evidence to verify that orlistat was the cause of the noted liver injuries. product or service assessment: I obtained this medication at the end of August & At the moment I weighed 11st